Here are five key notes:
1. The company is trading under the ticker symbol IVTY following its IPO pricing.
2. Invuity’s devices are already used in more than 400 hospitals and were implanted in 92,000 procedures as of March 2015.
3. The company revised its initial trading date and is expected to close on the initial public offering of 4 million shares of public stock on Thursday, June 18. This is one day later than expected.
4. The public offering is priced at $12 per share.
5. Piper Jaffray, Leerink Partners and Stifel are acting as joint book-running managers while William Blair is the acting co-manager of the offering.
More articles on orthopedic devices:
SpineGuard completes $3.1M fresh equity round—5 things to know
InVivo Therapeutics names Dr. James Guest to scientific advisory board—5 key notes
ApiFix used in 50th scoliosis correction—5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
